MR编号 | SI/H/0206/001 |
---|
药品名称 | Amoxicillin/clavulanic acid AptaPharma 1000 mg/200 mg powder for solution for injection/infusion |
---|
活性成分 | - Amoxicillin 1000.0 mg
- Clavulanic acid 200.0 mg
|
---|
剂型 | Powder for solution for injection/infusion |
---|
上市许可持有人 | Apta Medica Internacional d.o.o.
Likozarjeva Ulica 6
1000 Ljubljana
Slovenia |
---|
参考成员国 - 产品名称 | Slovenia (SI) Amoksicilin/klavulanska kislina AptaPharma 1000 mg/200 mg prašek za raztopino za injiciranje/infundiranje |
---|
互认成员国 - 产品名称 | - Austria (AT)
Amoxicillin/Clavulansäure AptaPharma 1000 mg/200 mg Pulver zur Herstellung einer Injektions-/Infusionslösung - Poland (PL)
- Hungary (HU)
Amoxicillin/Klavulánsav AptaPharma 1000 mg/200 mg por oldatos injekcióhoz vagy infúzióhoz - Bulgaria (BG)
Amopxicillin/Clavulanic acid AptaPharma - Czechia (CZ)
Amoxicillin/Clavulanic Acid AptaPharma 1000 mg/200 mg prášek pro injekční/infuzní roztok - Romania (RO)
Amoxicilină/Acid clavulanic AptaPharma 1000 mg/200 mg pulbere pentru soluție injectabilă/perfuzabilă - Slovakia (SK)
Amoxicilín/Kyselina klavulánová AptaPharma 1 000 mg/200 mg prášok na injekčný/infúzny roztok - Malta (MT)
- Croatia (HR)
Amoksicilin/klavulanska kiselina AptaPharma 1000 mg/200 mg prašak za otopinu za injekciju / infuziju
|
---|
许可日期 | 2021/01/07 |
---|
最近更新日期 | 2024/09/23 |
---|
药物ATC编码 | - J01CR02 amoxicillin and beta-lactamase inhibitor
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|